Form 10-Q Adamas Pharmaceuticals For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Adamas Pharmaceuticals (ADMS) Misses Q3 EPS by 13c
November 4, 2014 4:58 PM ESTAdamas Pharmaceuticals (NASDAQ: ADMS) reported Q3 EPS of ($0.57), $0.13 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Adamas Pharmaceuticals (ADMS) click here.
... More